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Abstract 
Background 
Mindfulness interventions are increasingly used as a part of integrated treatment in inflammatory 
bowel disease (IBD) but there are limited data and a lack of consensus regarding effectiveness.   
Objectives 
We explored the efficacy of mindfulness interventions compared to treatment as usual (TAU), or other 
psychotherapeutic interventions, in treating physical and psychosocial symptoms associated with IBD.  
Methods 
We conducted a systematic review and meta-analysis of relevant randomised controlled trials (RCTs). 
We included a broad range of mindfulness interventions including mindfulness-based interventions and 
yoga, with no restrictions on date of publication, participants’ age, language or publication type. We 
searched the following electronic databases: MEDLINE, EMBASE, PsycINFO, CINAHL and WHO ICTRP 
database. We adhered to the Preferred Reporting Items for Systematic Reviews and Meta-analysis 
(PRISMA) guidelines in conducting the review.  
Results 
We included eight studies in the meta-analysis. Mindfulness interventions showed a statistically 
significant effect on stress in both the short(SMD=-0.48; 95%CI:-0.97, 0.00; P=0.05), and long 
term(SMD=-0.55; 95%CI:-0.78, -0.32; P< 0.00001), significant long term effects on depression (SMD=-
0.36; 95%CI:-0.66, -0.07; P=0.02) and quality of life (SMD=0.38; 95%CI:0.08, 0.68; P=0.01),and small 
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but not statistically significant improvements in anxiety (SMD=-0.27; 95%CI:-0.65, 0.11; P=0.16).Effects 
on physical outcomes were  equivocal and not statistically significant. 
Conclusions 
Mindfulness interventions are effective in reducing stress and depression and improving quality of life 
and anxiety, but do not lead to significant improvements in the physical symptoms of IBD. Further 
research involving IBD-tailored interventions and more rigorously designed trials is warranted. 
Key words: IBD, mindfulness, systematic review. 
Registration details: International Prospective Register of Systematic Reviews (PROSPERO) 
registration number CRD42017080632 
Introduction 
Rationale 
IBD is an immune-mediated disease associated with chronic inflammation of the gastrointestinal tract 
and frequent extra-intestinal manifestations [1-3]. Individuals with IBD experience high burden of 
disease and significant mental health comorbidities [4].  Rates of depression and anxiety in periods of 
remission are two to three times higher than in age matched individuals in the general population [4, 
5]. During active disease, rates of  depression rise to over 60% with wide ranging implications in all 
areas of life[6]. Despite this,  treatment of depression and anxiety is not routinely included in standard 
IBD care, although there are recommendations for screening and treatment of depression and anxiety 
to be embeded in integrated IBD care [7]. 
 
There has been increasing research evidence outlining the impact of stress [8], anxiety and 
depression on the course of IBD [5], with a recent systematic review showing that depression and 
anxiety were independently associated with clinical recurrence of IBD [9].Mindfulness based 
interventions have been of particular interest in IBD due to their effectiveness in attenuating stress 
and treating depression and anxiety [10-12],as well as their potential to improve the course of IBD 
related to emerging evidence of their salutogenic impact on the immune system [13]. 
 
Mindfulness is defined as an experiential practice of focussing one’s attention with intention and 
without judgement[14]. While this definition of mindfulness is generally accepted, there is ongoing 
debate in the literature regarding the measuring and operationalization of mindfulness [15, 16]. 
Mindfulness Interventions include manualised mindfulness-based programs such as Mindfulness-Based 
Stress Reduction (MBSR) and Mindfulness-Based Cognitive Therapy (MBCT), mindfulness-informed 
interventions such as Dialectical Behaviour Therapy (DBT) and Acceptance and Commitment Therapy 
(ACT), modified mindfulness interventions and yoga. 
 
To our knowledge, there has been only one systematic review to date examining the efficacy and use 
of mindfulness interventions in IBD [17], published in 2015.  The review included manualised and 
adapted mindfulness programs published in English and German and it was restricted to adults. It 
found that no study showed significant group differences regarding physical or psychological variables 
in the main analysis, and that only a subset of patients with additional irritable bowel syndrome (IBS) 
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symptoms experienced significant improvements in quality of life. The review reported that the 
findings about the efficacy of mindfulness interventions in IBD were inconclusive, that these 
interventions might be useful in subgroup of IBD patients with IBS symptoms and that further research 
of higher methodological quality was needed.Two narrative reviews reported similar findings [18, 19].  
Since then, there have been several further RCTs of mindfulness interventions in IBD This systematic 
review therefore addresses the evidence gap by exploring a wide range of mindfulness interventions 
and including papers published in languages other than English and German and conducted in 
individuals of any age. 
 
Methods 
Objectives 
The aim of this systematic review was to evaluate the effectiveness of mindfulness interventions in the 
management of psychosocial and physical symptoms associated with IBD. We aimed to answer the 
following questions:  
1. Can mindfulness interventions improve psychological symptoms in IBD including depression, 
anxiety, stress and coping? 
2. Can mindfulness interventions improve quality of life (QoL) in IBD? 
3. Are mindfulness interventions effective in improving biological markers in IBD and other measures 
of IBD activity? 
 
Protocol and registration 
This systematic review  was registered with PROSPERO , an international database of prospectively 
registered systematic reviews (CRD42017080632) [20]. We followed the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses  (PRISMA) statement guidelines in designing this systematic 
review [21]. Ethical approval was not required as all included primary data had been previously 
published with ethical approval. 
 
Eligibility criteria 
We included RCTs of participants with IBD that compared interventions based on core mindfulness 
principles with TAU, waitlist or other psychosocial interventions using validated psychosocial and 
physical outcomes. 
 
Design of included studies 
Single-, double- or triple-blind RCTs were considered for inclusion. Studies published as abstracts were 
only included if the authors were contactable and further information provided to allow evaluation of 
study quality and main outcomes. Studies with a non RCT design and studies using non-validated 
outcome measures were excluded. 
 
Participants 
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Patients of any age, including paediatric populations, with a diagnosis of IBD were included. We 
specified that the IBD diagnosis was based on established criteria, such as the Montreal classification 
system, including confirmation with ileocolonoscopy and biopsies of the affected tissues [20]. Montreal 
classification is an integrated IBD diagnostic and classification system involving clinical, serological and 
genetic parameters, which has been widely used in clinical and research settings [22]. 
 
Interventions 
We adopted a broad definition of mindfulness interventions to include any therapy or program based 
on mindfulness principles and involving mindfulness practices. Interventions of interest included 
mindfulness-based programs, mindfulness-informed programs, adapted and shortened mindfulness 
interventions and yoga. Mindfulness-based programs included MBSR and MBCT which are evidence-
based, 8-week-long manualised group programs  taught in weekly 2-2,5 hours sessions encompassing 
multiple mindfulness components, homework exercises and usually a day of silent practice [14, 23-25]. 
Mindfulness-informed interventions included DBT, an experiential therapy using mindfulness as a 
foundation of  key DBT skills of distress tolerance, emotion regulation and interpersonal 
effectiveness[26], and ACT, a psychological intervention using acceptance and mindfulness strategies  
to increase psychological flexibility and commit to behaviour changes [27]. 
 
Abbreviated and adapted mindfulness Interventions such as Multi-Convergent Therapy (MCT) and 
Breath-Body-Mind-Workshop (BBMW) were also included in the review. MCT is a psychotherapeutic 
intervention combining mindfulness with cognitive behavioural techniques, usually delivered in six 
sessions over 16 weeks [28]. BBMW is an adapted  program combining mindful movement, breathing 
practices, and meditation, delivered as a two-day workshop followed by six weekly sessions and 
monthly booster sessions [29]. For the purposes of this review, we divided the interventions into yoga 
studies and mindfulness programs involving MBSR, MBCT, adapted mindfulness programs and 
mindfulness informed interventions.  
 
Comparators and context 
Controls in the review included wait list, standard medical treatment or treatment as usual (TAU), and 
other evidence-based psychological interventions. Studies in any clinical setting were included. 
 
Outcomes 
Studies examining IBD related psychological outcomes, quality of life and physical outcomes, assessed 
by validated screening tools were included. Psychological outcomes of interest included the following: 
rates of depression, anxiety and stress as assessed by validated screening tools such as Depression, 
Anxiety and Stress Scale (DASS), Beck Depression Inventory (BDI) and Hospital Anxiety and Depression 
Scale (HADS) and coping as measured by the Brief Cope Questionnaire (COPE). Quality of life was 
assessed by IBDQ or WHO-QoL. Physical outcomes included IBD activity as measured by biological 
markers of disease including local inflammatory markers such as faecal calprotectin (FCP), systemic 
inflammatory markers such as C-reactive protein (CRP) and Erythrocyte Sedimentation Rate (ESR), 
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White Cell Count (WCC) and haematocrit, investigations such as intestinal ultrasound, gastroscopy, 
endoscopy and colonoscopy, and IBD disease activity questionnaires such as a Simple Clinical Colitis 
Activity Index (SCAI) and Harvey Bradshaw Index (HBI). We extracted definitions of outcomes as 
reported in individual studies and recorded them in the data sheets in Covidence software [30] . 
 
Sources of information 
The following databases were searched: MEDLINE, EMBASE, PsycINFO and CINAHL. These electronic 
databases searches were supplemented by searches of trial protocols and systematic reviews in the 
Cochrane Central Register of Controlled Trials (CENTRAL), Australian and New Zealand Clinical Trials 
Register (ANZCTR), WHO International Clinical Trials Registry Platform (ICTRP) and the PROSPERO 
register of systematic reviews. We also scanned the reference and citation lists of included studies to 
improve literature coverage. We contacted the study authors for clarification and additional 
information when this was needed. The searches were re-run prior to review completion to ensure 
currency. 
 
Search strategies 
The specific search strategies were created by a health clinical librarian with expertise in systematic 
review searching (KR). Literature search strategies were developed using controlled vocabulary and 
text words related to mindfulness and IBD. MEDLINE (EBSCO) search including the following terms: 
1. MH ”Inflammatory Bowel Diseases” 
2. Crohn* 
3. Ulcerat* N3 Colitis 
4. IBD 
5. “Inflammatory Bowel Disease*” 
6. 1 OR 2 OR 3 OR 4 OR 5 
7. MH “Cognitive Therapy&#43;” 
8. Dialectic* N3 (therap* OR intervention* OR treatment* OR training OR counsel*)  
9. Mindful* 
10. (accept* OR commit*) N3 (therap* OR intervention* OR treatment* OR training) 
11. MH Yoga 
12. MH Meditation 
13. Yoga 
14. Meditat* 
15. 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 
16. PT “Randomized Controlled Trial” 
17. Random* N3 (allocat* OR trial*) 
18. RCT 
19. control* N3 trial* 
20. (singl* OR doubl* OR treb* OR tripl*) N3 blind* 
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21. 16 OR 17 OR 18 OR 19 OR 20 
22. 6 AND 15 AND 21 
 
Study records 
Data were managed by using EndNote and Covidence online software for conducting systematic reviews 
[30]. Literature search results were uploaded to EndNote and Covidence. Duplicate publications were 
excluded by visually inspecting abstracts and using EndNote. To reduce data entry errors, data  were 
entered into pre-created adapted data extraction forms in Covidence and exported directly into 
RevMan statistical analysis software [31]. Data were extracted by one reviewer (TE) and checked for 
errors by a second (KR). We used RevMan software to create a PRISMA flow diagram following the 
completion of the screening and data extraction. Figure 1 shows the PRISMA diagram depicting the 
flow of studies through the systematic review. 
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Figure 1: PRISMA flow diagram of the systematic review  
 
Data selection and extraction 
Two reviewers worked independently through all stages of the review, including screening papers for 
eligibility, examining full-text versions of studies for eligibility and inclusion in meta-analysis (TE, KR). 
Any disagreements were resolved through discussion with the third author (SK) and reasons for 
decisions documented.  
We extracted the following: 
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 general information (authors, year and country of origin) 
 trial methodology (study design, inclusion and exclusion criteria, study sample size and a priori 
sample size calculation) 
 participant characteristics (demographic information, IBD subtype and diagnosis and mental 
health diagnosis) 
 intervention characteristics (name, type, description, frequency, number and duration of 
sessions, length of the intervention, fidelity measures, therapists’ training) 
 types of control (wait-list, standard medical treatment or TAU, other psychological 
interventions) 
 outcome measures 
 results of main outcome measures including effect sizes  
 type and source of financial support  
Risk of bias (quality) assessment 
The methodological quality of the included trials was assessed independently by two reviewers using 
the Cochrane Collaboration's Assessment of Risk of Bias Tool [32]. We assessed risk of bias in the 
included studies against the six criteria from the Cochrane Risk of Bias Tool, including random 
sequence generation, allocation concealment, blinding of the participants  and the outcome assessors, 
incomplete data reporting, selective data reporting and other bias . We used risk of bias tables 
embeded in Covidence and adapted them by creating additional criteria involving interventions’ 
fidelity, validity of the outcome measures, inclusion and exclusion criteria and similarity of 
participants’ baseline characteristics. We evaluated each of the criteria in the risk of bias tool as low, 
high or unclear risk of bias and provided decisions justification. We did not assess publication bias due 
to having insufficient number of studies included in the review.  
Data synthesis 
 
We used statistical software RevMan 5.2, according to the guidelines referenced in the current version 
of the Cochrane Handbook for Systematic Reviews of Interventions [32].  The populations, 
interventions, controls and outcomes of the included studies were assessed as being sufficiently similar 
to combine for inclusion in meta-analyses to estimated pooled estimates of effect. Comparable 
outcome measures were identified and data on the mean and standard deviation were extracted for 
each outcome for each time-point of interest for each study. Because different instruments were used 
across studies, standardised mean differences were specified as the effect of interest. Because there 
were differences in the study populations, type of intervention and measures of effect, we assumed 
the effects being estimated by different studies were not identical and random-effects models were 
specified. Thus, the effect estimates provide an estimate of the average effect and the 95% confidence 
intervals reflect the degree of heterogeneity between studies. Heterogeneity was assessed using the I2 
statistic, with  scores 50% or greater indicating possible heterogeneity,and scores of 75– 100% 
indicating considerable heterogeneity [33]. Results were presented by the two subgroups of 
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mindfulness-based programs (MBPs) and yoga.  Where possible, we conducted sensitivity analyses for 
study quality or type of control. If any meta-analysis included 10 or more studies, we planned to test 
for publication bias using funnel plot asymmetry, but only eight studies were included.   In addition to 
quantitative analysis, we created an additional narrative summary, by using PICOS framework to 
explain the characteristics and findings of the included studies, in keeping with PRISMA statement 
recommendations [21].  
 
Results 
We identified 202 records and removed 37 duplicates  (Figure 1). We excluded a further 154 after 
screening titles and abstracts of the remaining 165 records. We examined the remaining 11 articles for 
eligibility and excluded 3 of them, two because of being conference abstracts which were superseded 
by the full text articles and one because of not having the RCT design. The remaining 8 studies  [34-41] 
were included in qualitative and quantitative analysis. Seven were full text articles and one was a 
conference abstract (Rowan 2017) which was assessed from the abstract content and by enlarging the 
reported graphs and then measuring and analysing the illustrated outcomes. 
 
Study characteristics 
Table 1 shows the characteristics of included studies. Studies were published between 2014 and 2017.  
Table 1, Summary of included studies characteristics 
Studies, 
country 
Design, 
control, 
setting 
Partic ipants 
dg, n, age, 
MBIs     Intervention 
length, N of 
sessions 
Primary 
outcome 
Psychologi-
cal 
Outcomes 
Physical              
outcomes      
Colle-    
c tion  
time 
points         
           
 Data    
Complete, 
ITT 
AminPur 
2015, 
Iran 
RCT, 
waitlist, 
outpatient 
UC, n=37, 
mean 
age=37.3 
ACT 8 weeks,  
 weekly  
CISS, 
problem-
oriented 
scale 
CISS, 
emotion & 
avoidance 
scales 
Nil               8 weeks     No, 
                  No 
Berril 
2014, UK 
RCT, 
waitlist, 
outpatient 
UC, CD; 
n=66, mean 
age=44.9   
MCT 16 weeks,  
6 sessions 
IBDQ PSQ, HADS, 
WCC, RDHS                                
Cumul. 
Relapse 
rate 
 
4M              No, 
8M              No 
12M        
Cramer 
2017, 
Germany           
RCT, written 
self-care, 
outpatient 
UC, n=77,  
mean 
age=45.5   
Yoga 12 weeks, 
weekly  
IBDQ PSS, HADS, 
PSQ, 
PANAS, 
BAQ, BRS  
CAI, FCP  
ESR, CRP 
12 weeks    Yes, 
 24 weeks    Yes 
Gerbarg 
2015, 
USA 
RCT, 
educational 
seminar, 
outpatient 
IBD, UC, 
CD, n=29, 
mean age 
54 
BBMW        6 weeks,                               
weekly 
sessions,  
Monthly 
boosters 
till week 26 
BSI-18
 
IBDQ, BAI, 
BDI, PDS, 
PSQ, BIPQ 
FCP, CRP,  
T, BP,  
pulse 
 
 6 weeks     No, 
 26 weeks     No 
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Jedel 
2014, 
USA 
RCT, time 
attention 
control, 
outpatient 
UC (in 
remission), 
n=53  
MBSR 8 weeks, 
weekly 
UC-DAI IBDQ, PSQ, 
BDI, STAI, 
MAAS 
CRP, FCP, 
IL6,8,1,      
ACTH, 
cortisol 
  8 weeks    No, 
   6M          No     
  12M         
Rowan 
2017, 
Ireland 
RCT, 
waitlist/TAU, 
outpatient 
IBD, n=95  
 
ACT 8 weeks,  
weekly 
DASS-
stress 
subscale 
DASS, 
anxiety, 
depression 
subscales 
FCP,  
CRP 
  8 weeks    No, 
  20 weeks  No 
Schoultz 
2015, UK 
RCT, 
waitlist, 
outpatient 
IBD, n=44  MBCT 8 weeks,  
weekly  
IBDQ BDI, STAI CDAI,  
SCCAI 
   8 weeks  Yes, 
    6M         No 
Sharma 
2015, 
India 
RCT, 
waitlist, 
outpatient 
UC + CD, 
n=100  
Yoga            8 weeks, 
1 week daily 
practice 
then 7 weeks 
home daily 
practice 
HRV  STAI ECP,               
 
 
Cardio-    
vascular 
reactivity 
  1M         Yes, 
    2M 
       
                 No 
 
MBIs: Mindfulness Based Interventions, CISS : Coping Inventory for Stressful Situations, IBDQ: Inflammatory Bowel Disease 
Questionnaire, PSQ: Perceived Stress Questionnaire, HADS: Hospital Anxiety and Depression Scale, WCC: Ways of Coping 
Checklist, RDHS: Revised Daily Hassle Scale, PSS: Perceived Stress Scale, PANAS: Positive and Negative Affect Scale, BAQ: Body 
Awareness Questionnaire, BRS: Body Responsiveness Scale, CAI: Clinical Activity Index, ESR: Erythrocyte Sedimentation Rate, 
CRP: C Reactive Protein, FCP: Faecal Calprotectin, BSI-18: Brief Symptom Inventory, BAI: Beck Anxiety Inventory, BDI: Beck 
Depression Inventory,  PDS: Perceived Disability Scale, BIPQ: Brief Illness Perception Questionnaire, BP: Blood pressure, T: 
temperature, UC DAI: Ulcerative Colitis Disease Activity Index, STAI: State and Trait Anxiety Inventory, MAAS: Mindful Attention 
Aw areness Scale , HRV: Heart Rate Variability, ECP: serum eosinophilic cationic protein, CDAI: Crohn’s Disease Activity Index , 
SCCAI: Simple Clinical Colitis Activity Index 
 
 
Study quality (Risk of Bias) 
Although all studies were described as RCTs, allocation concealment was not adequately described in 5 
out of the 8 included studies. Due to the nature of the intervention, it was difficult to blind the 
participants as they were aware of their group allocation in studies with waitlist and TAU 
controls. One of the studies who had control group comparable in both time and attention to 
the intervention, achieved participants blinding (Jedel 2014). Blinding of the assessors was 
not attempted in 2 out of 8 studies, 4 studies did not provide sufficient information about 
assessors’ blinding and 2 of the studies explained how assessors were blinded to group 
assignment. There was also a significant proportion of studies with incomplete reporting with 6 
studies having inadequate or incomplete data reporting. Only one of the studies employed Intention to 
Treat (ITT) analysis (Cramer 2017), while another employed modified ITT where participants who 
dropped out before the intervention onset were excluded (Jedel 2014). All the others used complete 
case or per protocol population analysis. The reasons for incomplete reporting were either omitting 
data reporting at certain time points, for example not reporting outcomes at therapy end and six 
months’ time points but reporting them at one-year follow-up (Jedel 2014), or not reporting certain 
outcomes, for example not reporting HADS scores after baseline (Berril 2014). 
Three out of eight studies described fidelity measures, both of the yoga studies and the MBCT study. 
The recorded fidelity measures included description of the intervention manual, facilitators adherence 
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to the manual, participants’ attendance and homework logs, and facilitators’ training and experience. 
Risk of bias assessment is presented in Table 2. 
 
Table 2, Risk of bias table 
 
  Amin
Pur 
2015 
Berril 
2014 
Cram
er 
2017 
Gerba
rg  
2015 
Jedel  
2014 
Rowan 
2017 
Schoultz 
2015 
Sharma 
2015 
Random sequence generation  
(selection bias) 
 
(high, low or unclear) 
Unclea
r 
Low Low High  Low Unclear Low Low 
Allocation concealment (selection bias) 
 
(high, low or unclear) 
Unclea
r 
Low Uncle
ar 
Uncle
ar 
Uncle
ar 
Unclear Low Low 
Blinding of participants, personnel 
(performance bias) 
 
(high, low or unclear) 
Unclea
r 
High High Uncle
ar 
Low Unclear High High 
Blinding of outcome assessment 
(detection bias) 
 
(high, low or unclear 
Unclea
r 
Unclear Low Uncle
ar 
Low Unclear High High 
Incomplete outcome data (attrition bias) 
 
(high, low or unclear) 
Uncle
ar 
High Low High Low Unclear High High 
Selective outcome reporting (reporting 
bias) 
 
(high, low or unclear) 
High Low Low Low Low Unclear Low High 
Other sources of bias 
 
(high, low or unclear) 
Uncle
ar 
Low Uncle
ar 
Uncle
ar 
High Unclear Low Unclear 
Fidelity measures 
(high, low or unclear) 
Uncle
ar 
High Low Uncle
ar 
Uncle
ar 
Unclear Low Low 
Validity of outcomes 
(high, low or unclear) 
Low Low Low Low Low Low Low Low 
Inclusion & exclusion criteria 
(high, low or unclear 
Low Low Low High Low Unclear Low Low 
Similarity of participants at baseline 
(high, low or unclear)                
Uncle
ar 
Low Low Uncle
ar 
High Unclear Unclear Low 
 
 
 
 
Participants’ characteristics 
All the participants were adults as no paediatric studies met the inclusion criteria. In all the studies, 
IBD was diagnosed with a combination of clinical, laboratory and endoscopic findings as per the widely 
accepted criteria. All studies enrolled individuals with quiescent IBD or IBD in remission and excluded 
individuals with significant mental health diagnoses.   
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Interventions Characteristics 
Two studies involved Mindfulness Based Programs (MBPs) ,  one MBSR [38] and one  MBCT[42] , two of 
the studies used ACT, one MCT, one BBMW and two studies delivered yoga.  Duration of therapy was 
between 6 and 12 weeks (Table 1). The shortest mindfulness intervention was BBMW with only 6 weeks 
duration, however it had an intensive two-day start and was followed by monthly booster sessions up 
till 26 weeks. The longest intervention was MCT of 16 weeks duration but with only 6 sessions   
delivering a similar “dose” of mindfulness practices to the other interventions.  
 
Comparators’ characteristics 
All included studies had a parallel group allocation design. Control groups were wait list patients in 
five out of eight studies, one had a written self-care control group and two studies had active controls. 
In both studies with active controls, participants in the control group were receiving treatment that 
mimicked the amount of time and attention received by the treatment group but thought not to have 
significant therapeutic effect, referred to as attention placebo control [43]. 
 
 Outcomes characteristics and outcomes collection time points 
Seven of the eight included studies measured both psychological and biological outcomes and all 
studies measured psychological outcomes. For the purpose of this review, we classified post treatment 
outcomes collection point as a short-term follow-up which occurred 6-16 weeks post baseline, 
depending on the length of the intervention. We defined long-term follow-up point as being between 
five months (20 weeks) and one-year post baseline, with one study assessing long-term outcomes at 20 
weeks (Rowan 2017), three at six months (Cramer 2017, Gerbarg 2015 and Schoultz 2015) and two at 
12-months post baseline (Berril 2014 and Jedel 2014).  
 
Psychological Outcomes Changes in Response to Mindfulness Interventions 
Eight studies were included in the meta-analysis, providing data for 251 participants who received 
mindfulness interventions and 249 waitlist, TAU or active controls (Table 1). Tables 3 and 4 show short 
and long-term changes in psychological outcomes. 
Table 3: Short-term psychological symptoms 
 
Outcome or Subgroup Studies Participants Standardised mean 
difference [95% CI] 
Depression scores at therapy end 3 127 -0.29 [-0.87, 0.29] 
  MBPs 2 50 0.01 [-0.55, 0.57] 
  Yoga 1 77 -0.68 [-1.14, -0.22] 
Anxiety scores at therapy end 4 179 -0.19 [-0.62, 0.24] 
  MBPs 2 51 0.06 [-0.86, 0.98] 
  Yoga 2 128 -0.36 [-0.76, 0.05] 
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Stress scores at therapy end 4 256 -0.48 [-0.97, 0.00] 
  MBPs 3 179 -0.51 [-1.20, 0.18] 
  Yoga 1 77 -0.36 [-0.81, 0.09] 
QoL scores at therapy end 4 185 0.22 [-0.07, 0.51] 
  MBPs 3 108 0.11 [-0.27, 0.49] 
  Yoga 1 77 0.37 [-0.08, 0.82] 
Coping scores at therapy end    
   MBPs 2 97 6.02 [-5.67, 17.72] 
  
 
Table 4 Long-term psychological symptoms 
 
Outcome or Subgroup Studies Participants  Standardised mean   
difference [95% CI] 
Depression scores   4 179 -0.36 [-0.66, -0.07] 
  MBPs 3 102 -0.19 [-0.58, 0.20] 
  Yoga 1 77 -0.61 [-1.06, -0.15] 
Anxiety scores   4 179 -0.27 [-0.65, 0.11] 
  MBPs 3 102 -0.07 [-0.46, 0.32] 
  Yoga 1 77 -0.66 [-1.12, -0.20] 
Stress scores   5 301 -0.55 [-0.78, -0.32] 
  MBPs 4 224  -0.51 [-0.77, -0.24] 
  Yoga 1 77 -0.67 [-1.13, -0.21] 
QoL scores   4 175 0.38 [0.08, 0.68] 
  MBPs 3 98 0.33 [-0.07, 0.74] 
  Yoga 1 77 0.45 [-0.01, 0.90] 
Coping scores      
  MBPs 1 51 0.64 [0.07, 1.20] 
     
 
Depression 
Depression scores were measured in four studies, three studies involving MBPs and one yoga study.  
There was no significant difference in depression scores between people who received mindfulness and 
those in the control group in the short-term. However, on subgroup analysis, it was apparent that the 
three studies of MBP showed no effect while the single yoga study was significantly better than TAU 
(Table 3).  By contrast, in the long-term, all the mindfulness interventions were significantly better 
than the control condition (Table 4 and Figure 2) although, again, the best result was for the single 
study of yoga.        
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Figure 2: Forest plot of short-term depression 
    
 
 
Figure 3: Forest plot of long-term depression 
 
 
 
Anxiety 
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Four studies assessed anxiety as an outcome, with 2 MBPs and 2 yoga studies reporting short-term 
anxiety scores (Table 3), and 3 MBPs and 1 yoga study reporting long-term anxiety scores (Table 4). 
When results from all studies were pooled, estimates were consistent with a small reduction in 
anxiety, which did not reach statistical significance in either the short- (Table 3) or long-term (Table 
4). Similarly, there were no significant differences between the intervention and control groups on 
subgroup analyses at any time point (Tables 3 and 4). The one exception was a single yoga study that 
reported a significantly greater improvement in anxiety at long-term follow-up (Table 4). 
 
Stress 
Of four studies assessing MBPs as the intervention and reporting stress as a long-term outcome, three 
included short-term measures at the end of the intervention period (Tables 3 and 4). Combining MBPs 
and yoga interventions in a single analysis resulted in statistically greater improvements in both the 
short-term (Table 3 and Figure 4) and long-term (Table 4 and Figure 5). These results were mirrored in 
the subgroup analyses of MBPs and yoga in the long-term (Table 4 and Figure 5) but not the short-term 
(Table 3 and Figure 4).   
 
 
 
 
Figure 4: Forest plot short term stress 
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Figure 5: Forest plot long term stress 
 
 
Coping scores 
Two studies reported on short-term outcomes and one in long-term outcomes. There were no 
significant differences between mindfulness and TAU at both intervals (Tables 3 and 4)  
  
 
Quality of Life Changes in Response to Mindfulness Interventions 
Three studies reported on the QoL outcome at each time-point but only two were common to both 
times.  When the mindfulness and yoga interventions were combined in a single analysis, there was 
evidence for a statistically greater improvement in the long-term effect estimates (Table 4 and Figure 
6), but not the short-term (Table 3).  None of the results in the subgroup analyses reached statistical 
significance (Tables 3 and 4). 
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Figure 6: Quality of life long term 
 
Physical Outcomes Changes in Response to Mindfulness Interventions 
There was limited information on physical disease outcomes, including systemic inflammatory markers 
(ESR/CRP), local inflammatory markers (FCP) and clinical disease activity. Only one MBP and one yoga 
study reported short term physical outcomes, both reporting non-significant results. The MBP reported 
clinical disease activity (SMD= -0.42; 95% CI:-1.77, 0.92; P=0.54) while the yoga study reported 
ESR/CRP (SMD=0.03; 95% CI:-0.41, 0.48;P=0.88 ), FCP (SMD=0.36; 95% CI:-0.09, 0.81;P=0.12), and 
clinical disease activity (SMD=-0.08; 95% CI:-0.53, 0.36; P=0.72). 
Long-term physical outcomes were reported by two MBPs and one yoga study. Two MBPs did not find 
statistically significant improvement in ESR/CRP (SMD=-0.25; 95% CI:-0.79, 0.30; P=0.37), FCP 
(SMD=0.22; 95% CI: -0.32, 0.76; P=0.42), and clinical disease activity (SMD=-0.57; 95%CI:-1.99, 0.86; 
P=0.44).The yoga study did not find significant improvement in ESR/CRP (SMD= -0.18; 95%CI:-0.63, 
0.27; P=0.44) and FCP (SMD=-0.18; 95%CI:-0.63, 0.26; P=0.42) but it did find statistically improved 
scores on the clinical disease activity index (SMD=-0.45; 95% CI:-0.90, 0.00; P=0.05).  
 
Heterogeneity and publication bias 
The short-term outcomes showed statistically significant heterogeneity, which is why we used random-
effects models. By contrast, there was no evidence of heterogeneity in the long-term results. We were 
unable to test for publication bias as none of meta-analyses of outcomes included 10 or more studies. 
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Discussion 
This review is the first systematic review to explore the efficacy of a broad range of mindfulness 
interventions in IBD while including all population ages and settings and posing no language or time and 
type of publication restrictions. It updates an earlier review of 2015 with more restrictive inclusion 
criteria and we were able to add six studies published since that meta-analysis. Broadening the 
definition of mindfulness interventions brought five additional studies, including 2 yoga studies, 2 
studies involving ACT, and one study involving an adapted mindfulness program (BMBW). Expanding the 
language only brought one additional study, published in Farsi, because the study conducted in 
Germany (Cramer 2017) and the study conducted in India (Sharma 2015) were both published in 
English. One of the authors (BA) translated the Iranian study. 
Expanding the age criteria did not bring any paediatric and adolescent studies as there were no RCTs in 
this age group despite a recent meta-analysis and a review showing that adolescents and young adults 
(AYAs) with IBD are particularly responsive to psychotherapy [18, 44], and that AYAs are responsive to 
mindfulness interventions [45, 46]. 
 
Overall findings of the review suggest that mindfulness interventions as a group are most effective in 
mitigating stress both the short- and long-term. In the short term, mindfulness interventions were only 
statistically superior to the control conditions in the case of stress  (Table 3 and Figure 4). However, on 
subgroup analysis, patients receiving yoga were significantly less depressed (Figure 2). In the longer-
term, symptoms of stress continued to improve with statistically significant differences in scores for 
both yoga and MBPs (Figure 5), and no differences for anxiety and depression in response to MBPs and 
mindfulness interventions as a group but only for yoga (Table 4). Improvements in quality of life were 
only statistically significant in the long-term. One of the yoga studies, Cramer et al, outperformed all 
other mindfulness interventions in depression, anxiety and stress scores changes both short and long-
term and in stress scores long-term. Care needs to be taken however when interpreting these results as 
they could be related to high methodological quality of this study rather than the type of the 
intervention. 
 
Interestingly, our results showed further decreases in stress scores on long term follow up, which is 
unusual in psychotherapy research where results usually fade with time. One explanation is that we 
were able to include one additional study in our long-term meta-analysis that may have increased 
precision by reducing 95% confidence intervals. Another explanation might be the effect of differential 
loss to follow-up. A third might be the long-term benefits of continuing with mindfulness practices. 
Reduction in stress offers a potential explanatory model for mindfulness mechanisms of action in IBD 
via the gut-brain axis and HPA axis modifications, leading to normalisation of psychological and 
biological markers via this pathway. This review, however, did not show significant improvement in 
biological markers for mindfulness interventions as a whole although both yoga studies showed 
reduction in inflammatory markers that did not reach statistical significance apart from clinical disease 
activity index which was statistically improved in yoga in comparison with the control group. It is 
important to consider these findings while keeping in mind that all of the studies excluded participants 
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with significant mental illness and active IBD. This resulted in enrolment of participants with low 
baseline levels of both psychological and biological parameters which made it more difficult to 
demonstrate improvement. 
 
Strengths and Limitations of the Review  
Strengths of this review are the inclusion of a broad range of mindfulness interventions and exploration 
the impact of mindfulness interventions on biological as well as psychological outcomes. Limitations of 
this review are that it has only eight included studies and with small sample sizes which resulted in 
limited sensitivity analysis and no assessment of publication bias. Furthermore, the quality of 
individual studies has been affected by poor blinding of the outcome assessors, incomplete data 
reporting and a relative lack of fidelity measures. The short-term outcomes showed statistically 
significant heterogeneity and should be viewed with caution even though we used random-effects 
models. An additional limitation is that included studies measured long-term outcomes at wide-ranging 
time frames, from 20 weeks (Rowan 2017) to one year (Jedel 2014 and Berril 2014). The review showed 
a relative lack of assessment of biological markers. 
 
This review highlights the need for rigorously designed studies with improved allocation concealment 
and blinding, more uniform follow-up time frames, and use of the ITT analysis and imputing of the 
missing data. The review suggests the need for mindfulness interventions that are tailored for IBD 
which could improve participants’ engagement and potentially increase their effect via a dose-
response relationship. In view of the beneficial impact of yoga, use of yoga-based programs and 
increase in yoga component in mindfulness programs may convey further benefits. Careful 
consideration of expansion of inclusion criteria to include participants with more severe IBD and 
psychological symptoms might be appropriate although limited by the impact of these conditions on 
participants’ ability to practice. Given the positive effect of mindfulness interventions on stress , 
depression and quality of life, and the impact of yoga on some physical outcomes, these therapies may 
be useful additions to integrative IBD care. 
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Highlights 
 Mindfulness interventions are effective in reducing stress, depression and anxiety and 
improving quality of life in individuals suffering from inflammatory bowel disease  
 Yoga-based programs are associated with significant improvements in depression, 
anxiety, stress and quality of life in inflammatory bowel disease, with moderate effect 
sizes on both short and long-term follow-up 
 Effects of mindfulness interventions on physical outcomes in inflammatory bowel 
disease are equivocal and not statistically significant 
 Mindfulness interventions may be useful additions to integrative IBD care 
 Further research involving IBD-tailored interventions and more rigorously designed trials 
is warranted 
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